Correspondence to Dr Jason W Boland, Hull York Medical School, University of Hull, Hull HU6 7RX, UK; Jason.Boland{at}hyms.ac.uk Objectives There is increased interest in cannabinoids for cancer pain ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

New Oral Drug to Calm Abdominal Pain Nov. 18, 2024 — Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that is based on the peptide hormone oxytocin ...

Cervical cancer symptoms are often absent in the early stages and may only become apparent when the disease is more advanced. Abnormal vaginal bleeding is the most common symptom overall, often ...

Jan. 23, 2025 — A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local ...

The research also points to important and perhaps underappreciated risks of these drugs. These risks primarily involved the digestive system and included nausea and vomiting, stomach pain ...

Warning over popular medication. Picture ... research is now needed to confirm our findings, given its minimal pain-relief effect, the use of paracetamol as a first-line pain killer for long ...